ArticleFrontiers in oncology2026
Treatment of parotid gland oncocytoma: a case report from a radiation oncologist's perspective.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parotid oncocytoma is a rare benign neoplasm for which surgical excision remains the standard treatment. Although the recurrence rate is generally low, it increases significantly in cases with multifocal lesions or incomplete surgical excision. In such scenarios, postoperative radiotherapy (RT) has been shown to improve local control, reduce recurrence rates, and minimize the need for reoperation. This report presents a representative case of parotid oncocytoma, with a focused discussion on therapeutic decision-making from a radiation oncologist's perspective. Case report: We report the case of a 61-year-old man who underwent left superficial parotidectomy for a firm mass located below his left ear. Postoperative pathological examination confirmed parotid oncocytoma. Contrast-enhanced computed tomography (CT) revealed an enhancing nodule in the deep portion of the left parotid gland, measuring 1.6 cm in maximum diameter. Following multidisciplinary team (MDT) discussion, postoperative radiotherapy was recommended to avoid potential facial nerve injury associated with repeat parotid surgery. Conclusion: This case illustrates the use of postoperative adjuvant radiotherapy for left parotid oncocytoma. Although parotid oncocytoma is benign, adjuvant radiotherapy may be considered in selected cases with a high risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.